Skip to content
Food and Agriculture Tech Series A Founded 2017

IBI-Ag

IBI-Ag is a manufacturer of bio-insecticides using antibody technology for crop protection. The company has developed natural single domain antibody insecticides to increase crop production, based on naturally-derived proteins with minimal impact on people, plants, and crops. The bio-insecticides are suitable for use against any type of insect pest, offering a sustainable alternative to traditional chemical…

📍 Ness Ziona, Israel · Crop Tech,

Funding snapshot

Last roundSeries A
Amount$10M
Date11 November 2025
Total raised$10M
Team size21

About

IBI-Ag is a manufacturer of bio-insecticides using antibody technology for crop protection. The company has developed natural single domain antibody insecticides to increase crop production, based on naturally-derived proteins with minimal impact on people, plants, and crops. The bio-insecticides are suitable for use against any type of insect pest, offering a sustainable alternative to traditional chemical pesticides. Founded in 2017 and headquartered in Ness Ziona, Israel, IBI-Ag has raised approximately 10 million at the Series A stage with investors including The Trendlines Group, Bayer, Corteva Agriscience, Iron Nation, Consensus Business Group, Innovation Israel, First Imagine, and Bandera.

Business model

Crop Tech > Farm Inputs > Biologicals > Crop Protection > Plant Based,

Chemicals Tech > Green Chemicals > Crop Protection > Plant Based

Institutional investors

The Trendlines Group Bayer Corteva Agriscience Iron Nation Consensus Business Group Innovation Israel First Imagine Bandera

Latest coverage

No articles yet.

Raising like IBI-Ag?

Analyze your pitch deck before your next raise.

Analyze My Deck →